- ¥4bn
- ¥998m
Annual balance sheet for Ribomic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,002 | 5,838 | 4,702 | 4,325 | 3,400 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 145 | 36.1 | 59.7 | 70.6 | 64.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,176 | 6,050 | 4,908 | 4,542 | 3,507 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 55.8 | 30.7 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,270 | 6,120 | 4,954 | 4,584 | 3,547 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 88.8 | 117 | 261 | 199 | 156 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 88.8 | 117 | 261 | 199 | 156 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,181 | 6,003 | 4,694 | 4,384 | 3,391 |
Total Liabilities & Shareholders' Equity | 2,270 | 6,120 | 4,954 | 4,584 | 3,547 |
Total Common Shares Outstanding |